Julie B. Engiles

Julie B. Engiles

Auto-generated profile, based on publicly available information

Julie B. Engiles

Department of Pathobiology, New Bolton Center, School of Veterinary Medicine University of Pennsylvania Kennett Square Pennsylvania USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
AZArielle Glatman Zaretsky
Arielle Glatman Zaretsky
JEJulie B. Engiles
Julie B. Engiles
CHChristopher A Hunter
Christopher A Hunter
The bone marrow (BM) is an important site for the interrelated processes of hematopoiesis, granulopoiesis, erythropoiesis, and lymphopoiesis. A wide variety of microbial challenges are associated with profound changes in this compartment that impact on hematopoietic differentiation and mobilization of a variety of cell types. This article reviews some of the key pathways that control BM homeostasis, the infectious and inflammatory processes that affect the BM, and how addressing the knowledge gaps in this area has the potential to widen our comprehension of immune homeostasis.

1 August 2012 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
SSSuzanne Stewart
Suzanne Stewart
SBStephanie Barr
Stephanie Barr
JEJulie Engiles
Julie Engiles
NHNoreen J. Hickok
Noreen J. Hickok
ISIrving M. Shapiro
Irving M. Shapiro
Thomas P SchaerThomas P Schaer
Thomas P Schaer
Early posttraumatic elbow contractures may be treated with a combination of manipulation with the patient under anesthesia followed by bracing.

15 October 2002 in Journal of the American Veterinary Medical Association
Verified
Journal Article
Closed access
TRTara S. Rabuffo
Tara S. Rabuffo
JOJames A. Orsini
James A. Orsini
ESEileen Sullivan
Eileen Sullivan
JEJulie Engiles
Julie Engiles
TNTracy Norman
Tracy Norman
RBRaymond Boston
Raymond Boston
Objective—To determine associations between age, sex, or medical treatment and prevalence and severity of gastric ulceration in Standardbred racehorses in training. Design—Cross-sectional study. Animals—224 Standardbred racehorses in training. Procedure—Gastroscopy was performed on each horse, and mucosal ulceration was graded from 0 (normal mucosa, no lesions) to 3 (extensive, often coalescing, lesions with areas of deep ulceration). Associations between age, sex, or treatment and prevalence and severity of ulcers were evaluated. Results—Prevalence of gastric ulceration was 87%. Although there was little association between age and prevalence of ulcers, there was an association between age and severity of ulcers. Most 2-year-old horses (57.7%) had an ulcer score of 0 or 1. In all other age groups, most (58% to 82.61%) of horses had an ulcer score of 2 or 3. Although overall prevalence of ulceration was comparable among sex groups, the relative risk for gastric ulceration increased with age in castrated males, whereas it decreased in females and sexually intact males. Conclusions and Clinical Relevance—Gastric ulceration is common in Standardbred horses in race training. Severity is higher in horses ≥ 3 years of age than in 2-year-old horses. Relative risk for ulceration increases with age in castrated males. (J Am Vet Med Assoc 2002;221:1156–1159)

1 April 2004 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
JRJohn P. Russell
John P. Russell
JEJulie B. Engiles
Julie B. Engiles
JRJay L. Rothstein
Jay L. Rothstein
RET/PTC3 (RP3) is an oncogenic fusion protein which is frequently expressed in papillary thyroid carcinomas and has been detected in thyroid tissue from patients diagnosed with Hashimoto’s thyroiditis. The constitutive activation of the tyrosine kinase domain in the carboxyl-terminal end of RP3 induces signaling pathways within thyrocytes and causes cellular transformation. One of the signaling pathways activated in RP3-expressing cells involves the activity of the transcription factor NF-κB and the production of downstream targets including GM-CSF and macrophage chemotactic protein 1. These factors are known to be immunostimulatory, making RP3 a molecular adjuvant and potentially promoting tissue-specific immunity. However compelling, these in vitro data do not reliably predict gene function in vivo or the cumulative effects of time-dependent processes such as angiogenesis, inflammation, or the influence of genetic background. To address these issues, we analyzed the production of proinflammatory mediators in mouse thyroid organs and demonstrate consistency with in vitro studies performed previously that Il1α, Il1β, Il6, and Tnfα and the enzyme Cox2 are produced by RP3-transgenic thyroid tissue, but absent from nontransgenic thyroids. Furthermore, we find that that the genetic background of the host is important in the observed RP3-induced inflammation and tumor progression. These findings provide support for the notion that oncogene-induced cytokine secretion is important for the development and progression of thyroid carcinomas in genetically permissive hosts.

3 July 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MDMichael I. Dishowitz
Michael I. Dishowitz
PMPatricia L. Mutyaba
Patricia L. Mutyaba
JTJoel D. Takacs
Joel D. Takacs
ABAndrew M. Barr
Andrew M. Barr
JEJulie B. Engiles
Julie B. Engiles
KHKurt D. Hankenson
Kurt D. Hankenson
The Notch signaling pathway is an important regulator of embryological bone development, and many aspects of development are recapitulated during bone repair. We have previously reported that Notch signaling components are upregulated during bone fracture healing. However, the significance of the Notch pathway in bone regeneration has not been described. Therefore, the objective of this study was to determine the importance of Notch signaling in regulating bone fracture healing by using a temporally controlled inducible transgenic mouse model (Mx1-Cre;dnMAMLf/-) to impair RBPjκ-mediated canonical Notch signaling. The Mx1 promoter was synthetically activated resulting in temporally regulated systemic dnMAML expression just prior to creation of bilateral tibial fractures. This allowed for mice to undergo unaltered embryological and post-natal skeletal development. Results showed that systemic Notch inhibition prolonged expression of inflammatory cytokines and neutrophil cell inflammation, and reduced the proportion of cartilage formation within the callus at 10 days-post-fracture (dpf) Notch inhibition did not affect early bone formation at 10dpf, but significantly altered bone maturation and remodeling at 20dpf. Increased bone volume fraction in dnMAML fractures, which was due to a moderate decrease in callus size with no change in bone mass, coincided with increased trabecular thickness but decreased connectivity density, indicating that patterning of bone was altered. Notch inhibition decreased total osteogenic cell density, which was comprised of more osteocytes rather than osteoblasts. dnMAML also decreased osteoclast density, suggesting that osteoclast activity may also be important for altered fracture healing. It is likely that systemic Notch inhibition had both direct effects within cell types as well as indirect effects initiated by temporally upstream events in the fracture healing cascade. Surprisingly, Notch inhibition did not alter cell proliferation. In conclusion, our results demonstrate that the Notch signaling pathway is required for the proper temporal progression of events required for successful bone fracture healing.

14 June 2021 in JOR SPINE
Verified
Journal Article
Open access
PDF file
NLNaomi N. Lee
Naomi N. Lee
ESElias Salzer
Elias Salzer
FBFrances C. Bach
Frances C. Bach
ABAndres F. Bonilla
Andres F. Bonilla
JCJames L. Cook
James L. Cook
MTMarianna Tryfonidou
Marianna Tryfonidou
Preclinical studies involving large animal models aim to recapitulate the clinical situation as much as possible and bridge the gap from benchtop to bedside. To date, studies investigating intervertebral disc (IVD) degeneration and regeneration in large animal models have utilized a wide spectrum of methodologies for outcome evaluation. This paper aims to consolidate available knowledge, expertise, and experience in large animal preclinical models of IVD degeneration to create a comprehensive tool box of anatomical and functional outcomes. Herein, we present a Large Animal IVD Scoring Algorithm based on three scales: macroscopic (gross morphology, imaging, and biomechanics), microscopic (histological, biochemical, and biomolecular analyses), and clinical (neurologic state, mobility, and pain). The proposed algorithm encompasses a stepwise evaluation on all three scales, including spinal pain assessment, and relevant structural and functional components of IVD health and disease. This comprehensive tool box was designed for four commonly used preclinical large animal models (dog, pig, goat, and sheep) in order to facilitate standardization and applicability. Furthermore, it is intended to facilitate comparison across studies while discerning relevant differences between species within the context of outcomes with the goal to enhance veterinary clinical relevance as well. Current major challenges in pre‐clinical large animal models for IVD regeneration are highlighted and insights into future directions that may improve the understanding of the underlying pathologies are discussed. As such, the IVD research community can deepen its exploration of the molecular, cellular, structural, and biomechanical changes that occur with IVD degeneration and regeneration, paving the path for clinically relevant therapeutic strategies.